In [**2138**], he underwent angioplasty to the left anterior descending coronary artery and has done well until [**Month (only) 547**] of this year when he started to have increased symptoms of chest pain and shortness of breath with exertion.
The patient underwent cardiac catheterization on [**2149-6-16**], which showed significant two vessel coronary artery disease and he was referred for coronary artery bypass graft.
Status post angioplasty in [**2138**].
Transurethral resection of the prostate for benign prostatic hypertrophy.
Atenolol 25 mg p.o.
Metformin 500 mg p.o.
Aspirin 325 mg p.o.
Niacin 500 mg p.o.
Glipizide 10 mg p.o.
Lipitor 20 mg p.o.
Zoloft 50 mg p.o.
HOSPITAL COURSE:  The patient was taken to the operating room on [**2149-6-17**], where he underwent coronary artery bypass graft times two with the left internal mammary artery to the left anterior descending coronary artery, saphenous vein graft to the obtuse marginal and saphenous vein graft to the diagonal with Dr. [**First Name4 (NamePattern1) **] [**Last Name (NamePattern1) **].
Postoperatively, the patient was transported from the operating room to the Cardiac Surgery Recovery Unit in good condition on Propofol drip.
He did remain somewhat hypotensive on the Neo-Synephrine intravenous drip.
He was treated with Amiodarone and Metoprolol and converted to normal sinus rhythm later that day.
The patient remained in the Intensive Care Unit over the next 48 hours, remained on Amiodarone drip and was ultimately transferred to the telemetry floor on Lopressor and Amiodarone on postoperative day number three.
The patient also on postoperative day number three was transfused one unit of packed red blood cells for hematocrit of 23.0 percent.
The patient began mobility, started to work with physical therapy and progressed with cardiac rehabilitation.
His Lopressor was ultimately discontinued for some sinus bradycardia.
He had his Amiodarone dose decreased over the next few days as well as for some bradycardia.
It was their recommendation not to change his oral hypoglycemic agents, but that he should follow-up with his lifestyle modification as well as diet control, and he should follow-up with the [**Hospital **] Clinic in two to three weeks upon discharge from the hospital.
The patient epicardial wires were discontinued earlier in the day today.
Zantac 150 mg p.o.
Aspirin 325 mg p.o.
Plavix 75 mg p.o.
Lasix 20 mg p.o.
Potassium Chloride 20 mEq p.o.
Glipizide 10 mg p.o.
Metformin 500 mg p.o.
Atorvastatin 20 mg p.o.
Zoloft 50 mg p.o.
Amiodarone 200 mg p.o.
Percocet 5/325 mg p.o.
DISCHARGE DIAGNOSES:  Coronary artery disease, status post coronary artery bypass graft.
